Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;41(11):3977-3981.
doi: 10.1007/s12325-024-02982-y. Epub 2024 Sep 9.

Striving for Stability in Patients with COPD: A New Way Forward?

MeiLan K Han  1 , Lowie E G W Vanfleteren  2 , Stefanie Kolterer  3 , Rianne Stacey  3 , Dave Singh  4
Affiliations

Striving for Stability in Patients with COPD: A New Way Forward?

MeiLan K Han et al. Adv Ther. 2024 Nov.

Abstract

This article summarises key themes from a symposium held during the recent European Respiratory Society congress, which took place in Vienna, Austria, 7-11 September 2024. The symposium was sponsored by GSK and entitled 'Striving for disease stability in COPD: Giving patients more of their best days'. During the session, the speakers (MeiLan Han, Lowie Vanfleteren and Dave Singh) highlighted the specific challenges of chronic obstructive pulmonary disease (COPD), such as its unpredictable and unstable nature, with additional insights provided from patients with COPD in the form of video interviews. The faculty discussed whether treatment standards and goals should be more ambitious to provide all patients the stability and predictability they deserve and the opportunity to do more while living with COPD.

Keywords: Chronic obstructive pulmonary disease; Exacerbations; Health status; Lung function; Treatment goals.

PubMed Disclaimer

Conflict of interest statement

MeiLan K. Han, Lowie E.G.W. Vanfleteren and Dave Singh received speaker fees to participate in the GSK-funded symposium on which this article is based; they did not receive payment for authoring the manuscript. Dave Singh is supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC). Stefanie Kolterer and Rianne Stacey are employed by, and hold financial equities in, GSK.

Figures

Fig. 1
Fig. 1
GOLD treatment goals for COPD [1]
Fig. 2
Fig. 2
Key considerations for keeping patients with COPD stable over time
Fig. 3
Fig. 3
Schematic of disease stability, a framework that aligns to current treatment recommendations by GOLD
See this image and copyright information in PMC

References

    1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2024 report). https://goldcopd.org/2024-gold-report/ (Accessed July 2024).
    1. World Health Organization. Chronic obstructive pulmonary disease (COPD). 16 March 2023. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul...) (Accessed July 2024).
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2020 to 2030. PLoS Med. 2006;3:e442. - PMC - PubMed
    1. Rennard S, Decramer M, Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey. Eur Respir J. 2002;20:799–805. - PubMed
    1. Jones PW, Watz H, Wouters EFM, Cazzola M. COPD: the patient perspective. Int J Chron Obstruct Pulmon Dis. 2016;19:11(Spec Iss):13–20. - PMC - PubMed

LinkOut - more resources